Category: Education
-
Appendix cancer biomarker testing usually means several separate tests, and they do not always agree with each other. A case report posted in August 2026 describes a young woman whose MMR protein test and MSI test gave opposite answers, and what her doctors did once they stopped treating one of those results as the whole…
-
Yes, an appendix abscess can be associated with an underlying appendiceal tumor. A 2025 prospective study of 370 patients with an abscess around the appendix found tumors in 14.3 percent, compared with 1.5 percent of patients with uncomplicated appendicitis. Nearly all of those tumors were in patients over 35. New imaging research published on August…
-
The retracted fenbendazole study that keeps circulating was pulled by its journal on January 21, 2026. It described three patients. None of them had appendix cancer. Someone sends me a fenbendazole link almost every week. It’s a dog dewormer. The claim is that it cures cancer, and the claim almost always arrives with a paper…
-
Short answer: On August 26, 2026, the FDA approved Rasonque (daraxonrasib), the first RAS drug approved for pancreatic cancer and the first that blocks multiple mutant forms of RAS at once. The approval covers metastatic pancreatic adenocarcinoma only. There is no approved RAS inhibitor appendix cancer patients can get today. The FDA just approved the…
-
Short answer: Ibrance appendix cancer research has now run for ten years, and it shows that palbociclib has activity in mucinous appendiceal tumors with GNAS mutations and may slow their growth. It is not a cure. Dr. Andrew Lowy says the next step is pairing it with the new KRAS drugs, and a trial built…
-
A wild type appendix cancer result means the test did not detect a mutation in the genes it was set up to examine. It does not mean your tumor has no mutations, and it does not mean the drugs built for wild type colon cancer will work for you. My husband David had his appendix…